Abcsofhealth,
I understand your view. If you take a close look at the report, and read it entirely, you will see that there is a difference in the stated numbers for R&D. Lets take 2004 and 2005:
"An estimate of the amount spent during each of the last two fiscal years on research and development activities, and, if applicable, the extent to which the cost of such activities are borne directly by customers.
In fiscal year 2004, the Company spent approximately $350,000 on research and development. In fiscal year 2005, the Company spent approximately $300,000 on research and development."
Than, further down the report:
2004: RESEARCH AND DEVELOPMENT $ 106,268,-
2005: RESEARCH AND DEVELOPMENT $ 103,307,-
TATA! There is a difference. This must have to do with the extent to which the cost of such activities are borne directly by customers. Correct?
Now you said: FOR 1 QTR 2006: RESEARCH AND DEVELOPMENT $ 8,006
Formerly you are correct. But this $ 8,006,- does not include the cost of such activities which are borne directly by customers. Nobody knows that number yet.
Thats why I say that its better to look at CTKH on a year to year basis.
By the way, its easy to compare apples with oranges with this report. I don't blame you. It does appear that the costs of R&D are indeed declining. From $ 350.000 in 2004 to $ 300.000 in 2005.
2006 could be different. I don't know. Maybe $ 250.000,- ? That's just a wild guess.
Good luck,
Ceteksevenmillion